A compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2
Abstract In December 2019, China reported the first cases of the coronavirus disease 2019
(COVID‐19). This disease, caused by the severe acute respiratory syndrome–related …
(COVID‐19). This disease, caused by the severe acute respiratory syndrome–related …
Antibody detection assays for COVID‐19 diagnosis: an early overview
The ongoing pandemic of coronavirus disease 2019 (COVID‐19) has not only commenced
a global health emergency but also agitated various aspects of humanity. During this period …
a global health emergency but also agitated various aspects of humanity. During this period …
Longitudinal serological analysis and neutralizing antibody levels in coronavirus disease 2019 convalescent patients
F Muecksch, H Wise, B Batchelor… - The Journal of …, 2021 - academic.oup.com
Background Understanding the longitudinal trajectory of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) antibodies is crucial for diagnosis of prior infection and …
coronavirus 2 (SARS-CoV-2) antibodies is crucial for diagnosis of prior infection and …
Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2
SN Neerukonda, R Vassell, R Herrup, S Liu, T Wang… - PloS one, 2021 - journals.plos.org
Pseudoviruses are useful surrogates for highly pathogenic viruses because of their safety,
genetic stability, and scalability for screening assays. Many different pseudovirus platforms …
genetic stability, and scalability for screening assays. Many different pseudovirus platforms …
[HTML][HTML] SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021
Abstract Background Earlier serosurveys in India revealed seroprevalence of severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) of 0.73% in May–June 2020 and 7.1% in …
respiratory syndrome coronavirus-2 (SARS-CoV-2) of 0.73% in May–June 2020 and 7.1% in …
[HTML][HTML] Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays
L Weidner, S Gänsdorfer, S Unterweger… - Journal of Clinical …, 2020 - Elsevier
Since the emergence of SARS-CoV-2 numerous antibody assays have become available,
demonstrating different performance characteristics. This study focused on a quantitative …
demonstrating different performance characteristics. This study focused on a quantitative …
Performance and operational feasibility of antigen and antibody rapid diagnostic tests for COVID-19 in symptomatic and asymptomatic patients in Cameroon: a clinical …
Y Boum, KN Fai, B Nikolay, AB Mboringong… - The Lancet Infectious …, 2021 - thelancet.com
Background Real-time PCR is recommended to detect SARS-CoV-2 infection. However,
PCR availability is restricted in most countries. Rapid diagnostic tests are considered …
PCR availability is restricted in most countries. Rapid diagnostic tests are considered …
Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods
Neutralizing antibodies targeting the receptor-binding domain (RBD) of the SARS-CoV-2
spike (S) block severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) entry into …
spike (S) block severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) entry into …
Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019
E Kowitdamrong, T Puthanakit, W Jantarabenjakul… - PloS one, 2020 - journals.plos.org
Background A greater understanding of the antibody response to SARS-CoV-2 in an
infected population is important for the development of a vaccination. Aim To investigate …
infected population is important for the development of a vaccination. Aim To investigate …
IFCC interim guidelines on serological testing of antibodies against SARS-CoV-2
Serological testing for the detection of antibodies against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) is emerging as an important component of the clinical …
coronavirus 2 (SARS-CoV-2) is emerging as an important component of the clinical …